SPLITOAK STRATEGIES LLC for CARIS LIFE SCIENCES, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
HR 2407/S 2085 The Medicare Multi-Cancer Early Detection Screening Coverage Act; Appropriate payment and coverage criteria for certain advanced diagnostic tests
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KUEHL EGGE | Legislative Assistant to Senator Bob Kerrey (1998-2000); Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (2001-2012); Deputy Staff Director\, Joint Select Committee on Deficit Reduction (Fall 2011) |
| AMY JENSEN | Special Assistant to the President for Legislative Affairs; Assistant to the Speaker for Policy; Legislative Assistant; Policy Analyst |
Medical/Disease Research/Clinical Labs MED
Ensuring access to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; Use of real-world evidence in clinical trials and FDA review; Cancer Moonshot; FDA proposed regulation to provide oversight of diagnostic lab tests (FDA-2023-N-2177)
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN | — |
Health Issues HCR
Providing an appropriate regulatory model for advanced genomic cancer testing (FDA-2023-2177), Artificial Intelligence proposals
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.